In-house roundup: Antibody possession test uncertainty; fintech patent investment divide; SPCs for other industries
Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX
Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

In-house roundup: Antibody possession test uncertainty; fintech patent investment divide; SPCs for other industries

Drugs

Managing IP rounds up the latest news and analysis from patent-focused businesses on fintech innovation, Section 112 and whether SPCs should be extended to agriculture and medical devices

Drugs

SCOTUS antibody case refusal raises Section 112 uncertainty

The US Supreme Court’s refusal to hear Amgen v Sanofi has renewed doubts over the value of antibody patents. Pharma firms such as Novartis and Bristol-Myers Squibb say they are exploring new ways to protect their innovations. Read More...

Agriculture companies disagree on need for SPCs

With high R&D costs and long development timelines, some agricultural firms argue that SPCs would bolster innovation in their field. Others say these extensions don’t fit with market dynamics and are not needed. Read more...

Innovation raises fintech patent investment challenges for traditional firms

Financial services businesses reveal the challenges behind how they allocate their patent budgets and choose between bread-and-butter legacy tech and revolutionary solutions they could monetise to generate high returns. Read more... 

Should medical device companies get SPCs?

Medical device firms in the US can apply for patent term extensions if they require regulatory approval before going to market, and some in-house counsel argue that the same rules should apply to European SPCs. Read more...

Sign up to receive more content like this in Patent Strategy’s weekly newsletter.




more from across site and ros bottom lb

More from across our site

In the first of a two-part UPC special, lawyers at A&O Shearman explain what you need to know about changes of procedural language and security for costs
Lawyers in the US and Europe reveal the work they focus on, how they stay one step ahead of creative counterfeiters, and why reputation matters
Abion said the appointment of Silvia Asioli and the launch of its Milan office will expand its market position in southern Europe
UK firms who have hired litigation and transactional lawyers reveal how they work together and the lessons have they learned
Jonah Mitchell tells us why he would have liked to have tried his hand at being a firefighter or chef
Noemi Parrotta, chair of the European subcommittee within INTA’s International Amicus Committee, explains why we might not have heard the last of the morality debate
Counsel say the USPTO's examples of AI patentability should make their lives easier and help point clients in the right direction
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
Ehsun Forghany says he was impressed by the firm's focus on fashion and IP as well as the expertise of chairman Anthony Lupo
Counsel at medical device companies say the unitary patent, AI and terminal disclaimers are major areas of concern
Gift this article